Greenyn Biotechnology Co (ROCO:6846) Long-Term Capital Lease Obligation : NT$53.7 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Greenyn Biotechnology Co Long-Term Capital Lease Obligation?

Greenyn Biotechnology Co's Long-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was NT$53.7 Mil.

Greenyn Biotechnology Co's quarterly Long-Term Capital Lease Obligation increased from Sep. 2023 (NT$41.2 Mil) to Dec. 2023 (NT$55.9 Mil) but then declined from Dec. 2023 (NT$55.9 Mil) to Mar. 2024 (NT$53.7 Mil).

Greenyn Biotechnology Co's annual Long-Term Capital Lease Obligation increased from Dec. 2021 (NT$42.9 Mil) to Dec. 2022 (NT$46.4 Mil) and increased from Dec. 2022 (NT$46.4 Mil) to Dec. 2023 (NT$55.9 Mil).

Greenyn Biotechnology Co Long-Term Capital Lease Obligation Historical Data

The historical data trend for Greenyn Biotechnology Co's Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Greenyn Biotechnology Co Long-Term Capital Lease Obligation Chart

Greenyn Biotechnology Co Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Long-Term Capital Lease Obligation

54.62

50.20

42.86

46.41

55.92

Greenyn Biotechnology Co Quarterly Data
	Dec19	Jun20	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Long-Term Capital Lease Obligation	Get a 7-Day Free Trial										44.60	43.08	41.22	55.92	53.69

Greenyn Biotechnology Co (ROCO:6846) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

Greenyn Biotechnology Co Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Greenyn Biotechnology Co's Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Greenyn Biotechnology Co (ROCO:6846) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Greenyn Biotechnology Co Ltd (ROCO:6846) » Definitions » Long-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

5th Floor, No 43 Keya Road, Daya District, Taichung, TWN

Website

https://www.greenynbio.com

Greenyn Biotechnology Co Ltd has developed Insumate patented sequenced peptide, Antromax Antrodia cinnamomea mycelia, and Zymologist fermented liquid.

Greenyn Biotechnology Co (ROCO:6846) Headlines

No Headlines